A sense-antisense RNA interaction promotes breast cancer metastasis via regulation of NQO1 expression

Antisense RNAs are ubiquitous in human cells, yet their role is largely unexplored. Here we profiled antisense RNAs in the MDA-MB-231 breast cancer cell line and its highly lung metastatic derivative. We identified one antisense RNA that drives cancer progression by upregulating the redox enzyme NADPH quinone dehydrogenase 1 (NQO1), and named it NQO1-AS. Knockdown of either NQO1 or NQO1-AS reduced lung colonization in a mouse model, and investigation into the role of NQO1 indicated that it is broadly protective against oxidative damage and ferroptosis. Breast cancer cells in the lung are dependent on this pathway, and this dependence can be exploited therapeutically by inducing ferroptosis while inhibiting NQO1. Together, our findings establish a role for NQO1-AS in the progression of breast cancer by regulating its sense mRNA post-transcriptionally. Because breast cancer predominantly affects females, the disease models used in this study are of female origin and the results are primarily applicable to females.

A systematic CRISPR screen defines mutational mechanisms underpinning signatures caused by replication errors and endogenous DNA damage

Mutational signatures are imprints of pathophysiological processes arising through tumorigenesis. We generated isogenic CRISPR-Cas9 knockouts (Δ) of 43 genes in human induced pluripotent stem cells, cultured them in the absence of added DNA damage, and performed whole-genome sequencing of 173 subclones. ΔOGG1, ΔUNG, ΔEXO1, ΔRNF168, ΔMLH1, ΔMSH2, ΔMSH6, ΔPMS1, and ΔPMS2 produced marked mutational signatures indicative of being critical mitigators of endogenous DNA modifications. Detailed analyses revealed mutational mechanistic insights, including how 8-oxo-dG elimination is sequence-context-specific while uracil clearance is sequence-context-independent. Mismatch repair (MMR) deficiency signatures are engendered by oxidative damage (C>A transversions), differential misincorporation by replicative polymerases (T>C and C>T transitions), and we propose a 'reverse template slippage' model for T>A transversions. ΔMLH1, ΔMSH6, and ΔMSH2 signatures were similar to each other but distinct from ΔPMS2. Finally, we developed a classifier, MMRDetect, where application to 7,695 WGS cancers showed enhanced detection of MMR-deficient tumors, with implications for responsiveness to immunotherapies.

An antibody that prevents serpin polymerisation acts by inducing a novel allosteric behaviour

Serpins are important regulators of proteolytic pathways with an antiprotease activity that involves a conformational transition from a metastable to a hyperstable state. Certain mutations permit the transition to occur in the absence of a protease; when associated with an intermolecular interaction, this yields linear polymers of hyperstable serpin molecules, which accumulate at the site of synthesis. This is the basis of many pathologies termed the serpinopathies. We have previously identified a monoclonal antibody (mAb4B12) that, in single-chain form, blocks α1-antitrypsin (α1-AT) polymerisation in cells. Here, we describe the structural basis for this activity. The mAb4B12 epitope was found to encompass residues Glu32, Glu39 and His43 on helix A and Leu306 on helix I. This is not a region typically associated with the serpin mechanism of conformational change, and correspondingly the epitope was present in all tested structural forms of the protein. Antibody binding rendered β-sheet A - on the opposite face of the molecule - more liable to adopt an 'open' state, mediated by changes distal to the breach region and proximal to helix F. The allosteric propagation of induced changes through the molecule was evidenced by an increased rate of peptide incorporation and destabilisation of a preformed serpin-enzyme complex following mAb4B12 binding. These data suggest that prematurely shifting the β-sheet A equilibrium towards the 'open' state out of sequence with other changes suppresses polymer formation. This work identifies a region potentially exploitable for a rational design of ligands that is able to dynamically influence α1-AT polymerisation.

Effect of lameness on estrous behavior in crossbred cows

Lameness, a common disease in crossbred dairy cows, badly affects their fertility. To elucidate, if estrous behavior, comprising of duration and expression of certain estrous behavioral sign(s) (EBS), is involved, an estrous expression score system was applied to objectively compare estrous behavior during 27 and 58 estrous periods, respectively, in 17 normal and 37 lame cows kept in a group of 200 cows under loose housing system in tropical India. The cows were detected in estrus and were closely watched daily for 30 min at 0630, 1030, 1430 and 1830 h from the beginning to the end of estrus. The duration of estrus was similar in the normal and the lame cows (18.7+/-1.2 h versus 17.2+/-0.9 h) and almost similar EBS were shown by two types of cows, albeit with varying frequency. Standing to be mounted, the highest ranking EBS was shown by equal proportions of the cows in both the groups (76.4% versus 73.0%). A lower proportion of lame cows showed head side mounting (35% versus 53%; P<0.05). The frequency of standing to be mounted events was lower in the lame than in the normal cows (2.4+/-0.4 versus 8.0+/-2.5; P<0.05). The lame cows earned non-significantly lower than normal estrous behavior score (1100+/-179 versus 1610+/-357). Further, the presence of more than one cow simultaneously in estrus enhanced the estrous behavior score in the normal (406.4+/-63.0 for one cow in estrus versus 793.0+/-146.0 for three cows simultaneously in estrus; P<0.05), but not in the lame cows. Lameness appeared to have suppressed the playful behavior during estrus probably owing to pain related stress. It is concluded that mildly lame cows appear to have normal physiological estrus. However, some of the EBS remain subdued which prone them to remain undetected for timely breeding.

A study of the acaricidal properties of an essential oil extracted from the leaves of Ageratum houstonianum

Study on acaricide property of foam soap containing essential oil of Ageratum houstonianum leaves was tested on Rhipicephalus lunulatus. Four doses of the oil (0.00, 0.02, 0.025 and 0.03 microl/g) with four replications for each dose were used in vitro. Each replication consisted of 10 ticks in a Petri dish with filter paper impregnated uniformly with the foam soap on the bottom. The same four doses in three replications were used in vivo. Each replication was made up of 10 naturally ticks infested goats. Results of this study indicate that foam soap containing essential oil of A. houstonianum leaves is toxic to R. lunulatus. The in vitro mortality rate was observed to vary from 0 to 50% on day 8 after treatment with the controls as compared to 95% with the lowest dose (0.02 microl/g) on day 8 and 100% with the highest dose (0.03 microl/g) on day 3. Meanwhile, the in vivo mortality rate was observed to be 23.4% with the control on day 8 after treatment whereas the highest dose killed 95.1% of the ticks by this day. The LD50 of the foam soap containing essential oil of this plant was 0.0259 and 0.0173 microl/g on day 2 after treatment, in the laboratory and on the farm, respectively. This indicates a potentially high efficiency of this medicated soap on this parasite.

Enhancing reproductive performance in dairy buffalo: major constraints and achievements

Buffalo are of high economic importance for farmers in several developing countries but reproductive performance is poor. A large proportion of heifers attain puberty at 3-5 years of age. A good quality diet supplemented with extra nutrients reduces the age of puberty, whereas the effects of administration of exogenous GnRH or equine chorionic gonadotrophin (eCG) are equivocal. The incidence of anoestrus in buffalo ranges from 20 to 80% depending on season. Most buffalo cease ovarian cyclicity during hot summers probably due to the combined effects of nutrition, environment and management. Keeping buffalo cool by wallowing, water sprinklers or shade improves fertility. Supplementary feeding with Urea Molasses Multi-nutrient Blocks (UMMB) for 60 days before calving enhances the early onset of postpartum oestrus. Regular UMMB supplementation also improves pregnancy rates in anoestrous non-pregnant buffalo. Prepartum vaginal prolapse is hereditary and eradication can be achieved by genetic selective breeding programmes. Treatment with calcium, phosphorus and progesterone gives only transient relief to clinical cases. Uterine torsion is the most common cause of dystocia (70%). Deployment of Sharma's detorsion method and anti-stress measures increase survival rates in cases presented within 36 h. In conclusion, greater understanding about the effects of better year-round nutrition, improved management and markers for logical breeding programmes are essential to curtail the incidence of the reproductive disorders that reduce buffalo fertility.

The reproductive pattern and efficiency of female buffaloes

Buffaloes play a prominent role in rural livestock production, particularly in Asia. Reproductive efficiency is the primary factor affecting productivity and is hampered in female buffalo by (i) inherent late maturity, (ii) poor estrus expression in summer, (iii) distinct seasonal reproductive patterns, and (iv) prolonged intercalving intervals. Ovarian function is central to these issues; hence, the focal point of this review is ovarian function in Bubalus bubalis, particularly, in relation to seasonal changes. Ovarian anatomy, follicular and luteal development development, and hormonal profiles during the estrous cycle are discussed. Review of the literature revealed a paucity of critically derived information on follicular and ovulatory patterns in buffalo, particularly, in relation to seasonal estrus/birthing. Efforts may be directed at understanding the process (recruitment, development, atresia) and temporal pattern (follicle selection, dominance, subordinate follicle suppression, follicle numbers, and, preovulatory changes) of follicular dynamics using techniques which permit serial assessment of changes occurring over time. Emphasis may be directed towards investigating follicular "waves" as a functional unit, rather than the estrous cycle, in the context of whole animal endocrinology. The data obtained from such basic studies may then be used to develop and test models for enhancing reproductive efficiency.

Effectiveness of lipopolysaccharide as an intrauterine immunomodulator in curing bacterial endometritis in repeat breeding cross-bred cows

Antibiotics are usually used to combat microbial infections of the uterus, responsible for hindering establishment of pregnancy in cross-bred cows. The major disadvantages of antibiotics are: development of bacterial resistance, high costs and diminishing uterine defense mechanisms (UDM). As an alternative therapy, intrauterine application of Escherichia coli Lipopolysaccharide (E. coli LPS) as a uterine defense stimulator was used in this study in confirmed clinical cases of repeat breeding associated with bacterial endometritis. In the treated group (n=12), on the day of estrus, 100 microg of E. coli LPS dissolved in 30-ml sterile phosphate buffer saline (PBS) was infused intrauterine; while in the control group (n=12), only 30 ml of PBS was infused. Six-hour post-treatment, in the treatment group uterine washings showed a 100-fold increase in the total leucocytic count (TLC). Out of the cellular contents, more than 80% of the cells were recognised as neutrophils; above 60% were alive and their phagocytic activity was five bacteria/neutrophil. Such a cellular response was maintained until 72-h post-treatment. At the subsequent estrus period, the cervicovaginal mucus (CVM) became clear in 9 out of 12 cows (75%) and showed no bacterial growth. In the control group, similar micro-organisms were present in CVM of all the 12 cows before and after the PBS infusions. During the subsequent estrus, all nine cows with sterile CVM in the treatment group conceived while only one cow conceived from the control group. It was concluded that, administration of intrauterine E. coli LPS as single infusion in cows with bacterial endometritis stimulated UDM and cleared the infection within one estrous cycle, and thereby restoring fertility.

Ventricular tachycardia induced cardiomyopathy: improvement with radiofrequency ablation

Cardiomyopathy and congestive heart failure due to ventricular and supraventricular tachycardia is a well-recognized phenomenon. The mechanism of such cardiomyopathy is not clear. Ablation of the supraventricular tachycardia focus, either surgically or electrically, has been reported to result in the resolution of the left ventricular dysfunction. Similarly, the treatment of ventricular tachycardia with surgery or antitachycardia pacing has also been reported to result in improved ventricular systolic function. We present here a case of improvement in left ventricular systolic function after successful radiofrequency ablation of the ventricular tachycardia focus in the right ventricular outflow tract. We postulate that cardiomyopathy was due to the incessant or frequent ventricular tachycardia. To the best of our knowledge, this is the first such case being reported.

Acute reversal of pheochromocytoma-induced catecholamine cardiomyopathy

Pheochromocytoma is a rare neuroendocrine tumor. We report a case of pheochromocytoma-induced cardiomyopathy in an 18-year old white female. A review of the literature indicated that this is the most dramatic reversal of pheochromocytoma cardiomyopathy reported. With aggressive medical management, there was complete recovery of the hemodynamic, echocardiographic, and electrocardiographic abnormalities within 14 days. This case emphasizes the importance of aggressive and appropriate medical therapy in pheochromocytoma heart disease.

Opioid modulation of the hypothalamo-pituitary-adrenal axis in dairy cows

Plasma cortisol responses to an intravenous bolus treatment with 250 mg naloxone, 300 mg morphine or a combination, were studied in Holstein-Friesian cows; 4 in early lactation (29-43 d postpartum) and 7 in mid-lactation (90-155 d post-partum). Blood samples were collected every 15 min from 60 min before to 90 min after treatment. Naloxone induced an immediate increase in cortisol concentration, reaching a peak within 30 min. The cortisol response (area under the curve) was positively correlated with pre-naloxone cortisol concentrations (r = 0.7, p < 0.05). The mean increase in cortisol concentration after naloxone appeared to be lower in early lactation (1.8 ng/ml) than in mid-lactation (8.3 ng/ml). In contrast, morphine consistently suppressed mean tonic plasma cortisol concentration by 2.7 ng/ml below baseline for at least 90 min. When given with morphine, naloxone counteracted the suppressive effects; the cortisol response was similar to that after naloxone alone. A cow in mid-lactation, suffering from chronic lameness (joint infection), gave opposite results, i.e., treatment with morphine alone increased cortisol concentration, whereas morphine with naloxone did not result in the expected large increase in plasma cortisol concentration. In conclusion, the hypothalamo-pituitary-adrenal axis of dairy cows appears to be under suppressive opioidergic control. However, the opioidergic system involved in hypothalamo-pituitary-adrenal functions of an animal under chronic stress behaved in an opposite manner.

Lack of LH response to oestradiol treatment in cows with cystic ovarian disease and effect of progesterone treatment or manual rupture

The luteinising hormone (LH) surge in response to 1 mg oestradiol benzoate intramuscular injection was studied on 67 occasions in 45 cows with cystic ovarian disease 20 to 150 days post partum. Cows diagnosed as having luteal cysts were given 500 micrograms cloprostenol intramuscularly 24 hours before oestradiol, to induce luteolysis. Oestradiol benzoate was also given to eight post partum acyclic and eight cyclic cows and in all these cases a control LH response was characterised for comparison. Eight of 17 cows with luteal cysts (47 per cent), and 10 of 21 cows with follicular cysts (48 per cent), released LH in response to oestradiol. Some cows with cysts were given one of two treatments. Seven cows with follicular cysts were treated with a progesterone-releasing device (PRID) for seven days: all responded to a second oestradiol treatment given 24 hours after removal of the PRID. Luteal cysts in three cows and follicular cysts in nine cows were ruptured manually: only one cow (a luteal case) responded to the second oestradiol treatment given 24 hours after manual rupture. In eight cows initially diagnosed with luteal cysts, cloprostenol was not given and plasma progesterone concentration at the time of oestradiol treatment was high (over 0.9 ng ml-1): none released LH in response to oestradiol. As manual rupture did not improve the LH response to oestradiol, it is concluded that the defective LH response to oestradiol in cows with cystic ovarian disease was not influenced in the short-term by cyst fluid contents.(ABSTRACT TRUNCATED AT 250 WORDS)

Opioid involvement in LH release during the negative feedback effects of oestradiol and progesterone in dairy cows

To create a clearly defined and uniform feedback phase of oestradiol, 1 mg oestradiol benzoate (OE2) was injected i.m. either 15-43 days post partum in 7 cows (Expt 1), or 12 h after prostaglandin oestrus synchronization of 4 cyclic cows (Expt 2 and 3). An endogenous opioid peptide (EOP) antagonist (250 mg naloxone), an EOP agonist (300 mg morphine), or a combination of the two was given in Expt 1, 2 and 3 respectively as a single i.v. injection in cows 16-18 h after OE2, i.e. in the negative feedback phase and before the expected onset of an induced luteinizing hormone (LH) surge. Blood samples were collected every 15 min for 1 h before and 2 h after each treatment. In Expt 1, naloxone failed to increase LH release when given during the negative feedback phase, but caused excessive release in one cow in which the LH surge had just begun. In all cows in Expt 2, morphine suppressed LH release (P less than 0.05). In Expt 3, naloxone prevented the suppressive effects of morphine for the first hour after treatment; a transient rise in LH occurred in one cow in which treatment was given 1 h before the start of the LH surge. In Expt 4, 250 mg naloxone was injected i.v. into 4 cows that had a plasma progesterone concentration of 1.5-3.1 ng mL-1 in the luteal phase of the oestrous cycle: naloxone failed to increase LH concentrations. It is concluded that LH can be further suppressed by opiates given to cows during the negative feedback phase of oestradiol.(ABSTRACT TRUNCATED AT 250 WORDS)

Relationship between an increase in plasma cortisol during transport-induced stress and failure of oestradiol to induce a luteinising hormone surge in dairy cows

This study investigated whether the stress associated with a 30-minute journey in a truck could distort the oestradiol-induced surge of luteinising hormone (LH) in dairy cows. Altogether 20 journeys were monitored, 16 to 18 hours after intramuscular administration of 1 mg oestradiol benzoate (OE2). Plasma cortisol concentration was elevated (P less than 0.001) within 30 minutes of the start of each journey, even when the journey was repeated at about weekly intervals, indicating a lack of habituation. The LH surge in response to 11 OE2 treatments in nine non-cycling cows within 30 days after calving was either absent (one cow) or significantly delayed, of shorter duration or of lesser amplitude following transport, compared with untransported OE2-treated controls. However, in six cycling cows, 58 days or more after calving, transport affected the LH surge only once. Even in these cows, the LH surge did not start until the cortisol concentration returned to normal, which may suggest a transient postponement of the LH surge by transport. In conclusion, transport impaired the LH surge in early post partum cows with little or no effect after ovarian cyclicity was resumed. It is hypothesised that endocrine events leading to the onset of the LH surge are more vulnerable to stressors in early post partum cows and in the natural situation this might be responsible for the occurrence of anovulation and cystic ovarian disease.

Opioid modulation of tonic luteinizing hormone release in ovariectomized dairy cows

A possible role of endogenous opioid peptides (EOP) in regulating the release of luteinizing hormone (LH) in the absence of ovarian influence was investigated. Experiments were conducted on three lactating Holstein-Friesian dairy cows, 20-27 days after ovariectomy. The cows were bled before and after a single intravenous (i.v.) injection of either 250 mg of naloxone (EOP antagonist) or 300 mg of morphine (EOP agonist) or a combination of the two in Experiments 1, 2 and 3, respectively. The mean and basal LH concentrations and the LH pulse frequency and amplitude were compared before and after each treatment in each cow. Naloxone induced an immediate rise in LH concentration by 60-300% above the preceding baseline values. This rise lasted for 15-30 min in each cow, after which the normal rhythmic LH release continued. One cow (A) suffered discomfort and respiratory distress 15-25 min after naloxone administration and the mean and basal LH concentration dropped significantly. Morphine significantly reduced the mean LH concentration by decreasing the number and amplitude of LH pulses and the basal LH values in two cows, although the decrease in one was not significant. The mean LH concentration in each cow remained unaffected by the combined treatment of morphine and naloxone. In conclusion, the elevation of LH concentration by naloxone, the suppression of LH release by morphine and the reversal by morphine and naloxone of each other's effects suggest that EOP could be involved in the control of LH release in cows in the absence of ovarian influence.

Effects of naloxone on the oestradiol-induced LH surge and cortisol release in transported cows

Four control cows released a normal LH surge in response to 1 mg oestradiol benzoate i.m. Compared to controls, 30 min transport of 5 cows 16-18 h after oestradiol significantly delayed the onset (P less than 0.05), suppressed the amplitude (P less than 0.01) and reduced the total LH release (P less than 0.001) in 4 cows and totally blocked the surge in the 5th cow. Just before the onset of transport, 5 cows were given 250 mg naloxone i.v. In 3 cows, the LH surge was delayed and reduced in amplitude and duration and was totally blocked in the other two, i.e. naloxone did not avert the detrimental effects of transport. Transport stimulated cortisol release in cows. Cows given naloxone + transport released significantly more (P less than 0.001) cortisol than did those subjected to transport alone. In conclusion, naloxone appeared to have further stimulated the hypothalamopituitary-adrenal axis of cows under stress.

The relationship between milk yield and cystic ovarian disease in cattle

Studies were conducted to understand the relationship, if any, between the amount and pattern of milk yield and the occurrence of cystic ovarian disease (COD) in dairy cattle. More than 70 cows with cysts were compared with herd mates of similar lactation number. Total milk yield in lactations when cysts occurred and in the preceding lactations were not different from the corresponding lactations in control cows. Patterns of monthly milk yield did not differ between the two groups of cows. However, weekly analysis in early lactation revealed differences. Both groups of cows achieved peak yields at a similar time (5.4 +/- 1.2 vs 5.7 +/- 1.9 weeks post partum in normal vs cows with COD). However, owing to an early decline in yield of cows with COD, their duration of peak yield was significantly shorter (P less than 0.05) than in the control cows (3.2 +/- 2.2 vs 5.6 +/- 2.4 weeks). Both the attainment and the decline of peak yield occurred 5.6 (range = 2-15) weeks before the cysts were diagnosed. It is concluded that COD is not particularly a disease of higher yielding cows and that COD has no discernible effect on the milk yield or its pattern. It is speculated, however, that some cows in early lactation, while trying to meet the requirements of sustained peak milk production, are more susceptible to minor environmental changes (such as new social interactions, or changes in diet). These events may lead to a drop in milk production and disruption of events controlling normal ovulation, resulting in the formation of ovarian cysts.

Effect of endogenous and exogenous progesterone on the oestradiol-induced LH surge in dairy cows

Four cows released an LH surge after 1.0 mg oestradiol benzoate administered i.m. during the post-partum anoestrous period with continuing low plasma progesterone. A similar response occurred in the early follicular phase when plasma progesterone concentration at the time of injection was less than 0.5 ng/ml. Cows treated with a progesterone-releasing intravaginal device (PRID) for 8 days were injected with cloprostenol on the 5th day to remove any endogenous source of progesterone. Oestradiol was injected on the 7th day when the plasma progesterone concentration from the PRID was between 0.7 and 1.5 ng/ml. No LH surge occurred. Similarly, oestradiol benzoate injected in the luteal phase of 3 cows (0.9-2.1 ng progesterone/ml plasma) did not provoke an LH surge. An oestradiol challenge given to 3 cows 6 days after ovariectomy induced a normal LH surge in each cow. However, when oestradiol treatment was repeated on the 7th day of PRID treatment, none released LH. It is concluded that ovaries are not necessary for progesterone to inhibit the release of LH, and cows with plasma progesterone concentrations greater than 0.5 ng/ml, whether endogenous or exogenous, did not release LH in response to oestradiol.

Retrospective analysis of the efficacy of different hormone treatments of cystic ovarian disease in cattle

Cystic ovarian disease in cows was treated either with a single intramuscular injection of 500 micrograms cloprostenol, a prostaglandin F2 alpha analogue, in 77 cases of luteal cysts or with 500 micrograms gonadorelin or 20 micrograms buserelin, gonadotrophin releasing hormone or its analogue (GnRH), in 116 cases of follicular cysts. Recovery was defined as the absence of cysts and the formation of a corpus luteum either with or without observed oestrus within 10 days after treatment with cloprostenol and 15 days after treatment with GnRH. Recovery occurred in 65 per cent and 52.6 per cent of cases, respectively, in average times of 4.9 and 19 days. Fifteen days after treatment with GnRH, 20 cows with luteinised cysts were treated with cloprostenol and 15 recovered in a mean of 20.4 days, while 10 which still had follicular cysts, were given GnRH and one recovered 31 days after the beginning of treatment. Another 27 cows, in which cysts became luteinised, were treated with cloprostenol seven days after treatment with GnRH to give quicker (average 11.5 days) but poor (48 per cent) recovery and with a higher rate (33 per cent) of recurrence of cysts. A progesterone releasing intrauterine device was used in 25 cases of cystic ovarian disease, some of which had been previously treated. Sixty-eight per cent recovered in an average of 15 days. The proportions of cows becoming pregnant to one to three inseminations after the different methods of treatment were similar (77 to 94 per cent).(ABSTRACT TRUNCATED AT 250 WORDS)

Studies on serum progesterone levels in relation to occurrence of uterine torsion in buffaloes (Bubalus bubalis )

Serum samples from 32 buffaloes suffering from uterine torsion at approximately the completion of the gestation period were analyzed for progesterone concentrations by radioimmunoassay. Fifteen buffaloes had progesterone concentrations of more than 1.0 ng/ml (1.65 +/- 0.13 ng/ml; 1.1 to 2.8 ng/ml), while the serum progesterone concentrations of the remaining 17 buffaloes were below 1.0 ng/ml (599 +/- 59 pg/ml; 200 to 900 pg/ml). The occurrence of uterine torsion was associated with labour and/or abdominal pain around the expected time of parturition at the completion of the gestation period. High progesterone concentrations at labour in cases of torsion in almost half of the buffaloes may suggest that there were instances of premature labour resulting from an impaired hormonal milieu. Disturbances in the onset of labour owing to hormonal imbalance as evidenced by high progesterone levels may also contribute to the causation of uterine torsion. Cases of uterine torsion having low progesterone values are also discussed in this study.

Dystocia due to urinary bladder carcinoma in two water buffaloes (bubalus bubalis) — Clinical case report

Two buffaloes with full-term pregnancy suffered from dystocia because the cervix did not dilate in spite of strong labour pains and other parturition signs shown by each animal. The urinary bladder, cervix, vagina and surrounding area were very firm. Dead, emphysemated fetuses were removed by caesarean in each case and anuria was also noticed. One buffalo died and the other was euthanised after surgery because it did not improve. The post-mortem examinations revealed transitional cell carcinoma of urinary bladder infiltrating the cervix, vagina and surrounding area in each case.